Blackmores (BKL) – A balanced view on media speculation

Elio D'Amato

Lincoln Indicators

At this stage, our view is that preference for food security by the Chinese consumer outweighs the sensitivity of the demand pipeline to these incremental price changes in the products. Therefore, we believe that the medium-term demand pipeline will not be materially impacted. It would appear that the recent price moves are more of a symptom of speculation than fact at this stage. However, this reiterates the regulatory risk which exists in this market and should remain an ongoing consideration for investors. Lincoln Indicators continue to cover BKL as a Star Growth Stock with a valuation of $188.73.

Bellamy’s Australia Limited (BAL), who are also exposed strongly to the Chinese food security thematic via their organic infant formula product, calmed the nerves of the market Thursday with a confirmation that their products will continue to be allowed to enter China via the country’s free trade zones.

As BAL’s infant formula is currently registered with the Certification and Accreditation Administration in China (CNCA) that is sold via the Central Board of Excise and Customs (CBEC) channel (cross-border transactions), per guidance issued on 13 April 2016, it will not have to obtain CFDA formulation registration until 1 January 2018.

Given BAL’s current registration with the relevant regulatory bodies in China and their history of operations there, management expects to be able to navigate the accreditation process prior to 2018 and do not foresee any disruption to their access to the Chinese market.

Lincoln Indicators continue to cover BAL as a Star Growth Stock with a valuation of $15.85.

Original article from Lincoln Indicators blog:  (VIEW LINK)

Important: Lincoln Indicators Pty Limited ABN 23 006 715 573, as Corporate Authorised Representative of Lincoln Financial Group Pty Ltd ABN 70 609 751 966, AFSL 483167. This blog may contain general financial product advice. It has been prepared without taking account of your personal circumstances (including your objectives, financial situation or needs) and you should therefore consider its appropriateness in light of your objectives, financial situationand needs, before acting on it. You should read and consider our Disclaimer for more Important Information and our Financial Services Guide (FSG) which sets out key information about the services we provide. The Disclaimer and FSG are available at (VIEW LINK).

Lincoln, Lincoln Financial Group Pty Ltd and directors, employees and/or associates of these entities hold interests in these ASX listed companies. This position is disclosed within the Stock Doctor program and may change at any time without notice.

1 topic

Elio D'Amato
Director of Research & Education
Lincoln Indicators

Elio heads up the Lincoln Stock Doctor research team as well as being their chief educator and key media spokesman. Elio is also a regular fixture on ABC and Sky Business television networks.


No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.